Immunocore Holdings (IMCR) Change in Working Capital (2021 - 2022)
Immunocore Holdings (IMCR) posted Change in Working Capital of $79759.1 for Q4 2022, down 47.94% sequentially from $153211.3 in Q3 2022, and up 154.79% YoY from $31304.5 in Q4 2021.
Immunocore Holdings (IMCR) Change in Working Capital (2021 - 2022) Analysis & Trends
Immunocore Holdings has reported Change in Working Capital for 2 years, with the latest figure at $79759.1 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 79,759.13 |
| Dec 31, 2022 | 79,759.13 |
| Sep 30, 2022 | 153,211.28 |
| Sep 30, 2022 | 153,211.28 |
| Dec 31, 2021 | -145,585.15 |
| Dec 31, 2021 | -145,585.15 |